hypoglycemia and glp-1 receptor agonists acute diabetes complications in adults with type 1 diabetes Targeting GLP-1, GIP & GCG

& Malik, A

Published, peer-reviewed, placebo-controlled clinical trial data from some of the most rigorous obesity research ever conducted

With growing competition in the market, Calibrate recently cut 18% of its workforce as part of a pivot to focus on its employer business rather than direct-to-consumer, Stat reported

A 2025 article from SHRM reports a notable increase in the average representation of GLP-1 drugs used for weight loss in total annual claims for employers, increasing from 8.9 percent in 2024 to 10.5 percent in 2025

But the USDA reiterated that there is no regulatory standard for the term GLP-1 Friendly. Other companies are targeting GLP-1 users but not mentioning the drugs on their labels or menus

Kirstie Canene-Adams Beyond ingredients, Ingredion provides formulation expertise spanning satiety and sensory science, regulatory compliance and texture optimization